Related Experiment Video

Updated: Jun 9, 2025

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
05:02

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Published on: February 4, 2021

3.3K

Retinoic acid receptor responder 2 and lipid metabolic reprogramming: A new insight into brain metastasis

Lulu Wang1,2, Yan Gao1,2

  • 1Department of Human Anatomy, School of Basic Medical Sciences Capital Medical University Beijing China.

Cancer Innovation
|October 25, 2024
PubMed

Insights

RARRES2 deficiency promotes brain cancer metastasis by altering lipid metabolism via the PTEN-mTOR-SREBP1 pathway. Targeting this metabolic reprogramming may offer new treatments for brain cancer metastasis (BCBrM).

Area of Science:

  • Oncology
  • Metabolic Research
  • Neuroscience

Background:

  • The brain is a frequent site for carcinoma metastasis.
  • Metabolic reprogramming is essential for organ-specific metastasis, including to the brain.
  • Lipid metabolism plays a role in the central nervous system's metabolic adaptation.

Purpose of the Study:

  • To investigate the role of RARRES2 in lipid metabolic reprogramming during brain cancer metastasis (BCBrM).
  • To explore the PTEN-mTOR-SREBP1 pathway's involvement in RARRES2-mediated lipid metabolism.
  • To identify potential therapeutic targets for BCBrM by understanding the link between lipid metabolism and brain metastases.

Main Methods:

  • Analysis of RARRES2's effect on lipid metabolic reprogramming.
  • Investigation of the PTEN-mTOR-SREBP1 signaling pathway.
  • Examination of metabolic adaptation in the central nervous system.
  • Correlation of lipid metabolism with brain metastases formation.

Main Results:

  • RARRES2 deficiency was found to significantly affect lipid metabolic reprogramming.
  • This reprogramming occurred through the PTEN-mTOR-SREBP1 pathway.
  • RARRES2 deficiency was linked to the promotion of brain cancer brain metastasis (BCBrM).

Conclusions:

  • There is a critical connection between lipid metabolism and brain metastases.
  • Disrupting this intricate connection presents a potential therapeutic strategy for BCBrM.
  • Understanding RARRES2's role in lipid metabolism offers insights into treating brain metastases.
Keywords:
brain metastasesbreast cancerlipid metabolismretinoic acid receptor responder 2

More Related Videos

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis07:43

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

26.5K
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

17.9K

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K